Clinic
Sabine Urgent Care, LLC
Sabine Urgent Care, LLC was paid $2.54M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 68% of everything it billed.
33Billing provider infoSABINE URGENT CARE, LLC
MANY, LA 71449
MANY, LA 71449
33aNPI1104288976assigned 03/22/2016
33bProvider typeUrgent Care Clinic/Center
28Total paid$2.54M
24GClaims111,773
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Louisiana
Rank by total paid#21 of 98
Median peer was paid$694K
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,450 | $279K | |
| 2019 | 13,039 | $341K | |
| 2020 | 4,653 | $140K | |
| 2021 | 27,170 | $318K | |
| 2022 | 25,236 | $496K | |
| 2023 | 17,008 | $509K | |
| 2024incomplete | 12,217 | $459K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 68% | 31,246 | 17,624 | $1.73M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 16,062 | 10,630 | $393K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.9% | 20,914 | 12,642 | $125K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.7% | 3,757 | 2,479 | $120K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.5% | 1,205 | 945 | $64K |
| 99051 | 2.1% | 7,183 | 5,029 | $52K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 375 | 285 | $25K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,153 | 6,100 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,872 | 2,102 | $10K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,251 | 1,793 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,762 | 2,721 | $4K |
| 87807 | <1% | 192 | 146 | $2K |
29 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 27 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 274 | $970.98 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,360 | $745.88 |
| 81002 | <1% | 1,253 | $619.21 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 228 | $171.16 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 922 | $29.40 |
| 92551 | <1% | 359 | $23.92 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 498 | $18.26 |
| 83655 | <1% | 202 | $9.63 | |
| 85018 | <1% | 834 | $6.14 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 251 | $5.22 |
| 99173 | <1% | 432 | $3.53 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 414 | $3.01 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 55 | $0.16 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 55 | $0.12 |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 126 | $0.00 |
| 90686 | 0% | 18 | $0.00 | |
| 86308 | 0% | 24 | $0.00 | |
| 90716 | 0% | 46 | $0.00 | |
| 90651 | 0% | 21 | $0.00 | |
| 90670 | 0% | 91 | $0.00 | |
| 90707 | 0% | 45 | $0.00 | |
| 90633 | 0% | 42 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 111 | $0.00 |
| 90734 | 0% | 42 | $0.00 | |
| S0077 | Injection, clindamycin phosphate, 300 mg | 0% | 24 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 18 | $0.00 |
| 90715 | 0% | 15 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCROWE, ROBERT (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Professional Pediatrics, LLC | Leesville, LA | $10.20M |
| Sabine Urgent II, LLC | Leesville, LA | $835K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.